Skip to main content

Table 1 Demographic and clinical features for all patients

From: Concomitant boost IMRT-based neoadjuvant chemoradiotherapy for clinical stage II/III rectal adenocarcinoma: results of a phase II study

  n %
Gender   
  Male 62 79.5
  Female 16 20.5
Age, years   
  Median (min-max) 54(30–76)
Distance from anal verge   
  ≤ 5 cm 56 71.8
  > 5 cm 22 28.2
cT stage   
  T3 50 64.1
  T4 28 35.9
cN stage   
  N0 3 3.8
  N1 34 43.6
  N2 41 52.6
Total 78 100.0